Benefit–risk assessment

In Safety & pharmacovigilance

Benefit–risk assessment is the structured judgment of whether a treatment's likely benefits justify its known and potential harms in a defined population. It is made before a trial starts, revisited as safety data accumulates, and made again before approval. It is a judgment, not a calculation, and it can change.

Turn the vocabulary into a career

The free CRLN Career Finder maps your background to a clinical-research role and builds a step-by-step roadmap. No cost, no card.

Educational reference only. Where regional rules differ, follow the regulation and the written procedures that apply where you work.